During the first semester of 2009 Revista Médica de Chile has received an increasing number of manuscripts. Close to 30% were rejected while most other are in the process of being improved by the authors after receiving criticisms by external peer reviewers and the editors. The time lag between acceptance and publication of manuscripts is on an average six months. During 2008, 10% of articles published were submitted by authors from countries other than Chile and most of them were printed in English. Impact factor and other indexes provided by the ISI Web of Knowledge showed a promising improvement in 2008. The International Advisory Committee and the National Editorial Committee were renewed, a new Section on Laboratory Medicine was incorporated and several minor changes were done in design and format, in the title page and the issues' content. The main problems to be faced relate to the increasing cost of editing and printing, with a reduction in commercial advertising historically contributed by the pharmaceutical industry. Another major concern is to stimulate governmental agencies, scientific societies and universities to establish a national independent registry of clinical trials, that should become a mandatory requisite for every manuscript submitted to Chilean medical journals, reporting clinical trials performed in the country; foreign manuscripts should document the satisfaction of an identical requisite in their original source.